Go Pro
NASDAQ:AVR

Anteris Technologies Global Q3 2025 TU Earnings Report

Anteris Technologies Global logo
$10.24 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$10.24 -0.01 (-0.05%)
As of 07/2/2026 06:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Anteris Technologies Global EPS Results

Actual EPS
-$0.62
Consensus EPS
-$0.58
Beat/Miss
Missed by -$0.05
One Year Ago EPS
N/A

Anteris Technologies Global Revenue Results

Actual Revenue
$0.43 million
Expected Revenue
$0.74 million
Beat/Miss
Missed by -$307.00 thousand
YoY Revenue Growth
N/A

Anteris Technologies Global Announcement Details

Quarter
Q3 2025 TU
Time
Before Market Opens
Conference Call Date
Wednesday, November 12, 2025
Conference Call Time
6:00PM ET

Upcoming Earnings

Anteris Technologies Global's Q2 2026 earnings is estimated for Monday, August 10, 2026, based on past reporting schedules

Anteris Technologies Global Earnings Headlines

SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in 50 years - and it has nothing to do with a single stock. According to multiple Wall Street banks, a coming crisis could keep your portfolio in the red for 10 years or longer. Keith Kaplan, CEO of TradeSmith, is sharing what you can do to protect your wealth before it hits.tc pixel
See More Anteris Technologies Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Anteris Technologies Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anteris Technologies Global and other key companies, straight to your email.

About Anteris Technologies Global

Anteris Technologies Global (NASDAQ:AVR) engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

View Anteris Technologies Global Profile